US FDA approves IMRIS’ next generation VISIUS Surgical Theatre

Posted on Updated on


VISIUS Surgical Theatre

IMRIS Inc., a global leader in providing image guided therapy solutions, has received the US Food and Drug Administration clearance for newest generation VISIUS Surgical Theatre which integrates Siemens’ latest high-field MR scanners. The new core imaging technology based on Siemens Aera 1.5T(tesla) and Skyra 3.0T technology helps IMRIS deliver better image quality with higher signal-to-noise ratio, faster 3D image acquisition, and improved ease-of-use and workflow during neurosurgical procedures using intraoperative MRI (iMRI).

“These high-field intraoperative scanner options will give a hospital’s clinical team imaging applications and image quality that increase productivity,” said IMRIS president and CEO Jay D Miller. “We are bringing the latest and unequaled imaging technology into the operating room where it can make the most difference – during the surgery. IMRIS systems have been used in over 13,000 cases worldwide to improve outcomes in brain tumor and epilepsy surgeries in particular.”

The addition of these MR systems expands the industry-leading 1.5T and 3.0T MRI choices hospitals have when considering the unique, ceiling-mounted IMRIS solution for intraoperative imaging which brings the MRI to the patient during the procedure.

The first installation of this new generation VISIUS Surgical Theatre will be a four-room hybrid operating room suite, known as the Centre for Surgical Innovation (CSI) at Dartmouth-Hitchcock Medical Centre in Lebanon, Nebraska. “Surgeons are too often limited by what they cannot see –anatomy that is difficult to reach or diseases that are not visible to the naked eye,” says Sohail Mirza MD, medical director of CSI and chair of orthopedics at Dartmouth-Hitchcock. “The advanced integration of state-of-the-art imaging tools in CSI will allow surgeons and engineers to innovate like never before, rapidly developing, testing, and validating new surgical tools and techniques, with the goal of achieving better, safer, and, in some cases, less-costly care for patients everywhere.”

The Dartmouth-Hitchcock installation will also include a VISIUS intraoperative CT (iCT), which utilizes the technology of the 64-slice Siemens SOMATOM Definition AS scanner, making it the only operating suite in the world with both VISIUS iMRI and iCT modalities able to serve multiple operating rooms (ORs) without moving the patient.

Inside a VISIUS Surgical Theatre equipped with either high-field iMRI or iCT, surgeons have ondemand access to real-time data and state-of-the-art imaging, during the procedure from the OR table. The Company also designs and manufactures proprietary head fixation devices, imaging coils, and OR tables for use in this unique and multifunctional intraoperative environment.

IMRIS is a global leader in providing image guided therapy solutions through its VISIUS Surgical Theatre – a revolutionary, multifunctional surgical environment that provides unmatched intraoperative vision to clinicians to assist in decision making and enhance precision in treatment.

Source: PharmaBiz

Advertisements

Let us know what you think!

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s